Group A for Spinal Cord Injury

Phase < 1

Waitlist Available

Research Sponsored by Kessler Foundation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately post-training session (1 day)

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing how changes in brain activity relate to the intensity and unpleasantness of neuropathic pain in people with SCI.

Eligible Conditions

Nerve pain
Spinal Cord Injury

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately post-training session (1 day)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately post-training session (1 day)

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately post-training session (1 day) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Brain activity

Secondary study objectives

Exit Interview

Pain Intensity

Pain Unpleasantness

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Group BExperimental Treatment1 Intervention

Participants will be shown information about brain activity while trying different thinking strategies to change their experience of pain. Both groups will be shown brain activity, but the source of the brain activity information will differ between the groups.

Group II: Group AExperimental Treatment1 Intervention

Do I qualify?Apply below to find out